Cite
ANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T cell Patients
MLA
Jacinta, Perram, et al. “ANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T Cell Patients.” Internal Medicine Journal, May 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........37e1d6f0c243caaea647135038b57fcd&authtype=sso&custid=ns315887.
APA
Jacinta, P., Duncan, P., Ashish, B., Jason, B., Tracey, O., Benjamin, T., Nicole, G., Phoebe J, H., Richard, D., Thomas, H., Travis, P., Genevieve, D., Shanti, R., Lynette, C., Judith, T., Robert, W., Steven, K., Chris, F., Tara, C., … Nada, H. (2022). ANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T cell Patients. Internal Medicine Journal.
Chicago
Jacinta, Perram, Purtill Duncan, Bajel Ashish, Butler Jason, O’Brien Tracey, The Benjamin, Gilroy Nicole, et al. 2022. “ANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T Cell Patients.” Internal Medicine Journal, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........37e1d6f0c243caaea647135038b57fcd&authtype=sso&custid=ns315887.